Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Armadillo repeat-containing protein 3 (ARMC3) is a member of the armadillo-repeat protein family, characterized by imperfect 45-amino acid repeats (ARM domains) that enable protein-protein interactions[1][4][6]. ARMC3 has key roles in several cellular processes, especially autophagy and spermatogenesis, where it anchors autophagy machinery required for sperm development and mitochondrial function[1]. Loss of ARMC3 in animal models leads to sperm defects and infertility[1]. Human ARMC3 exhibits testis-preferential expression but is also identified as a cancer/testis antigen that may be aberrantly expressed in various tumors, suggesting a potential link to cancer biology[2][5][6]. ARMC3 may also participate in ciliary assembly and function in specific tissues[1]. There are currently no known drugs targeting ARMC3, and its mechanisms in disease remain under active investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Armadillo repeat-containing protein 3 (ARMC3).